{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:32:21Z","timestamp":1793835141572,"version":"4.6.1"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project of the Jiangsu Commission of Health","award":["K2023062"],"award-info":[{"award-number":["K2023062"]}]},{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202241"],"award-info":[{"award-number":["JSDW202241"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00903-5","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T07:17:12Z","timestamp":1770621432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Semaphorins: from CD8\u207a T cells to cancer immunotherapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Zhiying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"903_CR1","doi-asserted-by":"crossref","unstructured":"Teh SJ, Killeen N, Tarakhovsky A, et al. CD2 regulates the positive selection and function of antigen-specific CD4-CD8+ T cells [J]. Blood. 1997;15(4):1308\u201318.","DOI":"10.1182\/blood.V89.4.1308"},{"issue":"1","key":"903_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12943-024-01972-6","volume":"23","author":"S Peng","year":"2024","unstructured":"Peng S, Lin A, Jiang A, et al. CTLs heterogeneity and plasticity: implications for cancer immunotherapy [J]. Mol Cancer. 2024;23(1):21.","journal-title":"Mol Cancer"},{"issue":"12","key":"903_CR3","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1158\/2159-8290.CD-22-1301","volume":"13","author":"JH Rowe","year":"2023","unstructured":"Rowe JH, Elia I, Shahid O, et al. Formate supplementation enhances antitumor CD8+ T-cell fitness and efficacy of PD-1 blockade [J]. Cancer Discov. 2023;13(12):2566\u201383.","journal-title":"Cancer Discov"},{"key":"903_CR4","doi-asserted-by":"crossref","unstructured":"Camargo CP, Muhuri AK, Alapan Y, et al. Adhesion analysis via a tumor vasculature-like microfluidic device identifies CD8+ T cells with enhanced tumor homing to improve cell therapy [J]. Cell Rep. 2023;42(3).","DOI":"10.1016\/j.celrep.2023.112175"},{"key":"903_CR5","doi-asserted-by":"crossref","unstructured":"Mikucki ME, Fisher DT, Matsuzaki J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints [J]. Nat Commun. 2015;6(1).","DOI":"10.1038\/ncomms8458"},{"issue":"10","key":"903_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.neo.2019.08.003","volume":"21","author":"J Riegler","year":"2019","unstructured":"Riegler J, Gill H, Ogasawara A, et al. VCAM-1 density and tumor perfusion predict T-cell infiltration and treatment response in preclinical models [J]. Neoplasia. 2019;21(10):1036\u201350.","journal-title":"Neoplasia"},{"issue":"2","key":"903_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20061890","volume":"204","author":"A Boissonnas","year":"2007","unstructured":"Boissonnas A, Fetler L, Zeelenberg IS, et al. In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor [J]. J Exp Med. 2007;204(2):345\u201356.","journal-title":"J Exp Med"},{"issue":"5","key":"903_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1074-7613(01)00234-5","volume":"15","author":"JC Stinchcombe","year":"2001","unstructured":"Stinchcombe JC, Bossi G, Booth S, et al. The immunological synapse of CTL contains a secretory domain and membrane bridges [J]. Immunity. 2001;15(5):751\u201361.","journal-title":"Immunity"},{"issue":"3","key":"903_CR9","doi-asserted-by":"publisher","first-page":"e70253","DOI":"10.1002\/ctm2.70253","volume":"15","author":"X Xia","year":"2025","unstructured":"Xia X, Wu H, Chen Y, et al. Ferroptosis of T cell in inflammation and tumour immunity [J]. Clin Transl Med. 2025;15(3):e70253.","journal-title":"Clin Transl Med"},{"issue":"5","key":"903_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0896-6273(92)90237-8","volume":"9","author":"AL Kolodkin","year":"1992","unstructured":"Kolodkin AL, Matthes DJ, O\u2019connor T P, et al. Fasciclin IV: Sequence, expression, and function during growth cone guidance in the grasshopper embryo [J]. Neuron. 1992;9(5):831\u201345.","journal-title":"Neuron"},{"issue":"7","key":"903_CR11","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/eji.200535601","volume":"36","author":"Y Lepelletier","year":"2006","unstructured":"Lepelletier Y, Moura IC, Hadj-Slimane R, et al. Immunosuppressive role of semaphorin\u20103A on T cell proliferation is mediated by Inhibition of actin cytoskeleton reorganization [J]. Eur J Immunol. 2006;36(7):1782\u201393.","journal-title":"Eur J Immunol"},{"issue":"2","key":"903_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2326-6066.CIR-18-0156","volume":"7","author":"PE Clavijo","year":"2019","unstructured":"Clavijo PE, Friedman J, Robbins Y, et al. Semaphorin4D Inhibition improves response to immune-checkpoint blockade via attenuation of MDSC recruitment and function [J]. Cancer Immunol Res. 2019;7(2):282\u201391.","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"903_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4049\/jimmunol.1501293","volume":"196","author":"RH Younis","year":"2016","unstructured":"Younis RH, Han KL, Webb TJ. Human head and neck squamous cell carcinoma\u2013associated semaphorin 4d induces expansion of myeloid-derived suppressor cells [J]. J Immunol. 2016;196(3):1419\u201329.","journal-title":"J Immunol"},{"key":"903_CR14","doi-asserted-by":"crossref","unstructured":"K\u00f6rner A, Bernard A, Fitzgerald JC, et al. Sema7A is crucial for resolution of severe inflammation [J]. Proc Nat Acad Sci. 2021;118(9).","DOI":"10.1073\/pnas.2017527118"},{"issue":"1","key":"903_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1189\/jlb.0111031","volume":"91","author":"F Garcia","year":"2012","unstructured":"Garcia F, Lepelletier Y, Smaniotto S, et al. Inhibitory effect of semaphorin-3A, a known axon guidance molecule, in the human thymocyte migration induced by CXCL12 [J]. J Leukoc Biol. 2012;91(1):7\u201313.","journal-title":"J Leukoc Biol"},{"issue":"13","key":"903_CR16","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1073\/pnas.0700705104","volume":"27","author":"Y Lepelletier","year":"2007","unstructured":"Lepelletier Y, Smaniotto S, Hadj-Slimane R, et al. Control of human thymocyte migration by neuropilin-1\/semaphorin-3A-mediated interactions [J]. Proc Natl Acad Sci U S A. 2007;27(13):5545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6907","key":"903_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01037","volume":"10","author":"A Kumanogoh","year":"2002","unstructured":"Kumanogoh A, Marukawa S, Suzuki K, et al. Class IV semaphorin sema4A enhances T-cell activation and interacts with Tim-2 [J]. Nature. 2002;10(6907):629\u201333.","journal-title":"Nature"},{"issue":"3","key":"903_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4049\/jimmunol.1403038","volume":"195","author":"D Ito","year":"2015","unstructured":"Ito D, Nojima S, Nishide M, et al. mTOR complex signaling through the sema4A-plexinB2 axis is required for optimal activation and differentiation of CD8\u2009+\u2009T cells [J]. J Immunol. 2015;195(3):934\u201343.","journal-title":"J Immunol"},{"issue":"6","key":"903_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/2326-6066.CIR-14-0171","volume":"3","author":"EE Evans","year":"2015","unstructured":"Evans EE, Jonason AS, Bussler H, et al. Antibody blockade of semaphorin 4D promotes immune infiltration into tumor and enhances response to other immunomodulatory therapies [J]. Cancer Immunol Res. 2015;3(6):689\u2013701.","journal-title":"Cancer Immunol Res"},{"key":"903_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cytogfr.2020.05.006","volume":"57","author":"D Fard","year":"2021","unstructured":"Fard D, Tamagnone L. Semaphorins in health and disease [J]. Cytokine Growth Factor Rev. 2021;57:55\u201363.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"903_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1083\/jcb.201602002","volume":"216","author":"T Sun","year":"2017","unstructured":"Sun T, Yang L, Kaur H, et al. A reverse signaling pathway downstream of sema4A controls cell migration via scrib [J]. J Cell Biol. 2017;216(1):199\u2013215.","journal-title":"J Cell Biol"},{"issue":"1","key":"903_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ni1553","volume":"9","author":"K Suzuki","year":"2008","unstructured":"Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions [J]. Nat Immunol. 2008;9(1):17\u201323.","journal-title":"Nat Immunol"},{"issue":"8","key":"903_CR23","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00018-016-2137-x","volume":"73","author":"C Battistini","year":"2016","unstructured":"Battistini C, Tamagnone L. Transmembrane semaphorins, forward and reverse signaling: have a look both ways [J]. Cell Mol Life Sci. 2016;73(8):1609\u201322.","journal-title":"Cell Mol Life Sci"},{"key":"903_CR24","doi-asserted-by":"publisher","first-page":"123281","DOI":"10.1016\/j.lfs.2024.123281","volume":"361","author":"T Qamar","year":"2025","unstructured":"Qamar T, Misra DP, Kar S. Semaphorins and its receptors: emerging cellular biomarkers and therapeutic targets in autoimmune and inflammatory disorders [J]. Life Sci. 2025;361:123281.","journal-title":"Life Sci"},{"key":"903_CR25","doi-asserted-by":"crossref","unstructured":"Basile JR, Castilho RM, Williams VP, Silvio Gutkind J. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A. 2006;103(24):9017\u20139022.","DOI":"10.1073\/pnas.0508825103"},{"issue":"9","key":"903_CR26","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1074\/jbc.M609570200","volume":"282","author":"JR Basile","year":"2007","unstructured":"Basile JR, Holmbeck K, Bugge TH, et al. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D [J]. J Biol Chem. 2007;282(9):6899\u2013905.","journal-title":"J Biol Chem"},{"key":"903_CR27","doi-asserted-by":"crossref","unstructured":"Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A. 1996;93(21):11780\u201311785.","DOI":"10.1073\/pnas.93.21.11780"},{"key":"903_CR28","doi-asserted-by":"crossref","unstructured":"Aiyappa-Maudsley R, Mcloughlin LFV, Hughes TA. Semaphorins and their roles in breast cancer: implications for therapy resistance [J]. Int J Mol Sci. 2023;24(17).","DOI":"10.3390\/ijms241713093"},{"issue":"5","key":"903_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2015.04.013","volume":"42","author":"AT Ritter","year":"2015","unstructured":"Ritter AT, Asano Y, Stinchcombe JC, et al. Actin depletion initiates events leading to granule secretion at the immunological synapse [J]. Immunity. 2015;42(5):864\u201376.","journal-title":"Immunity"},{"issue":"4","key":"903_CR30","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI34388","volume":"118","author":"B Breart","year":"2008","unstructured":"Breart B, Lemaitre F, Celli S, et al. Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice [J]. J Clin Invest. 2008;118(4):1390\u20137.","journal-title":"J Clin Invest"},{"issue":"1","key":"903_CR31","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41467-019-11280-z","volume":"10","author":"M Leclerc","year":"2019","unstructured":"Leclerc M, Voilin E, Gros G, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by neuropilin-1 [J]. Nat Commun. 2019;10(1):3345.","journal-title":"Nat Commun"},{"issue":"1","key":"903_CR32","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41467-024-47424-z","volume":"15","author":"MB Barnkob","year":"2024","unstructured":"Barnkob MB, Michaels YS, Andre V, et al. Semmaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells [J]. Nat Commun. 2024;15(1):3173.","journal-title":"Nat Commun"},{"key":"903_CR33","doi-asserted-by":"crossref","unstructured":"Nijhara R, van Hennik PB, Gignac ML, Kruhlak MJ, Hordijk PL, Delon J, Shaw S. Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes. J Immunol. 2004;173(8):4985\u20134993.","DOI":"10.4049\/jimmunol.173.8.4985"},{"issue":"2","key":"903_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ni.1691","volume":"10","author":"M Bolomini-Vittori","year":"2009","unstructured":"Bolomini-Vittori M, Montresor A, Giagulli C, et al. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module [J]. Nat Immunol. 2009;10(2):185\u201394.","journal-title":"Nat Immunol"},{"issue":"12","key":"903_CR35","doi-asserted-by":"publisher","first-page":"e0145218","DOI":"10.1371\/journal.pone.0145218","volume":"10","author":"X Yan","year":"2015","unstructured":"Yan X, Yan M, Guo Y, et al. R-ras regulates murine T cell migration and intercellular adhesion molecule-1 binding [J]. PLoS ONE. 2015;10(12):e0145218.","journal-title":"PLoS ONE"},{"issue":"24","key":"903_CR36","doi-asserted-by":"publisher","first-page":"8293","DOI":"10.1523\/JNEUROSCI.0799-12.2012","volume":"32","author":"G Tasaka","year":"2012","unstructured":"Tasaka G, Negishi M, Oinuma I. Semaphorin 4D\/Plexin-B1-mediated M-Ras GAP activity regulates actin-based dendrite remodeling through lamellipodin [J]. J Neurosci. 2012;32(24):8293\u2013305.","journal-title":"J Neurosci"},{"issue":"4","key":"903_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1083\/jcb.200508204","volume":"173","author":"I Oinuma","year":"2006","unstructured":"Oinuma I, Katoh H, Negishi M. Semaphorin 4D\/Plexin-B1-mediated R-Ras GAP activity inhibits cell migration by regulating beta(1) integrin activity [J]. J Cell Biol. 2006;173(4):601\u201313.","journal-title":"J Cell Biol"},{"key":"903_CR38","doi-asserted-by":"crossref","unstructured":"Chuckran CA, Liu C, Bruno TC, et al. Neuropilin-1: A checkpoint target with unique implications for cancer immunology and immunotherapy [J]. J Immunother Cancer, 2020;8(2).","DOI":"10.1136\/jitc-2020-000967"},{"key":"903_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2018.01.040","volume":"418","author":"J Wang","year":"2018","unstructured":"Wang J, Huang Y, Zhang J, et al. Nrp-2 in tumor lymphangiogenesis and lymphatic metastasis [J]. Cancer Lett. 2018;418:176\u201384.","journal-title":"Cancer Lett"},{"issue":"10","key":"903_CR40","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/febs.13711","volume":"283","author":"YC Tsai","year":"2016","unstructured":"Tsai YC, Fotinou C, Rana R, et al. Structural studies of neuropilin-2 reveal a zinc ion binding site remote from the vascular endothelial growth factor binding pocket [J]. FEBS J. 2016;283(10):1921\u201334.","journal-title":"FEBS J"},{"issue":"37","key":"903_CR41","doi-asserted-by":"publisher","first-page":"25110","DOI":"10.1074\/jbc.C800137200","volume":"283","author":"C Prahst","year":"2008","unstructured":"Prahst C, Heroult M, Lanahan AA, et al. Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1 [J]. J Biol Chem. 2008;283(37):25110\u20134.","journal-title":"J Biol Chem"},{"issue":"1","key":"903_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0092-8674(00)80063-X","volume":"99","author":"L Tamagnone","year":"1999","unstructured":"Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates [J]. Cell. 1999;99(1):71\u201380.","journal-title":"Cell"},{"issue":"1","key":"903_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0092-8674(00)80062-8","volume":"99","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Fournier A, Nakamura F, et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors [J]. Cell. 1999;99(1):59\u201369.","journal-title":"Cell"},{"issue":"5","key":"903_CR44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1074-7613(00)00062-5","volume":"13","author":"A Kumanogoh","year":"2000","unstructured":"Kumanogoh A, Watanabe C, Lee I, et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100 a novel mechanism for regulating B cell signaling [J]. Immunity. 2000;13(5):621\u201331.","journal-title":"Immunity"},{"issue":"8","key":"903_CR45","doi-asserted-by":"publisher","first-page":"e0203419","DOI":"10.1371\/journal.pone.0203419","volume":"13","author":"R Correa-Rocha","year":"2018","unstructured":"Correa-Rocha R, Lopez-Abente J, Gutierrez C, et al. CD72\/CD100 and PD-1\/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72\/CD100 axis is correlated with T-cell exhaustion [J]. PLoS ONE. 2018;13(8):e0203419.","journal-title":"PLoS ONE"},{"issue":"8","key":"903_CR46","doi-asserted-by":"publisher","first-page":"e0203419","DOI":"10.1371\/journal.pone.0203419","volume":"30","author":"R Correa-Rocha","year":"2018","unstructured":"Correa-Rocha R, Lopez-Abente J, Gutierrez C, et al. CD72\/CD100 and PD-1\/PD-L1 markers are increased on T and B cells in HIV-1\u2009+\u2009viremic individuals, and CD72\/CD100 axis is correlated with T-cell exhaustion [J]. PLoS ONE. 2018;30(8):e0203419.","journal-title":"PLoS ONE"},{"issue":"18","key":"903_CR47","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0960-9822(07)00421-6","volume":"10","author":"Y Wu","year":"1998","unstructured":"Wu Y, Nadler MJ, Brennan LA, et al. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1 [J]. Curr Biol. 1998;10(18):1009\u201317.","journal-title":"Curr Biol"},{"issue":"4","key":"903_CR48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00281-008-0137-0","volume":"30","author":"TM Mccaughtry","year":"2008","unstructured":"Mccaughtry TM, Hogquist KA. Central tolerance: what have we learned from mice? [J]. Semin Immunopathol. 2008;30(4):399\u2013409.","journal-title":"Semin Immunopathol"},{"issue":"6","key":"903_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.it.2012.03.005","volume":"33","author":"G Anderson","year":"2012","unstructured":"Anderson G, Takahama Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection [J]. Trends Immunol. 2012;33(6):256\u201363.","journal-title":"Trends Immunol"},{"issue":"6","key":"903_CR50","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni.1868","volume":"11","author":"H Phee","year":"2010","unstructured":"Phee H, Dzhagalov I, Mollenauer M, et al. Regulation of thymocyte positive selection and motility by Git2 [J]. Nat Immunol. 2010;11(6):503\u201311.","journal-title":"Nat Immunol"},{"issue":"7","key":"903_CR51","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.4049\/jimmunol.1302585","volume":"192","author":"M Korthals","year":"2014","unstructured":"Korthals M, Schilling K, Reichardt P, et al. Alphapix Rhogef supports positive selection by restraining migration and promoting arrest of thymocytes [J]. J Immunol. 2014;192(7):3228\u201338.","journal-title":"J Immunol"},{"issue":"4","key":"903_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1084\/jem.20040643","volume":"200","author":"T Ueno","year":"2004","unstructured":"Ueno T, Saito F, Gray DH, et al. CCR7 signals are essential for cortex-medulla migration of developing thymocytes [J]. J Exp Med. 2004;200(4):493\u2013505.","journal-title":"J Exp Med"},{"issue":"1","key":"903_CR53","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1038\/s41598-017-05182-7","volume":"7","author":"B Lucas","year":"2017","unstructured":"Lucas B, White AJ, Parnell SM, et al. Progressive changes in cxcr4 expression that define thymocyte positive selection are dispensable for both innate and conventional alphabeta-cell development [J]. Sci Rep. 2017;7(1):5068.","journal-title":"Sci Rep"},{"key":"903_CR54","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ncomms2105","volume":"3","author":"Y Ueda","year":"2012","unstructured":"Ueda Y, Katagiri K, Tomiyama T, et al. Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus [J]. Nat Commun. 2012;3:1098.","journal-title":"Nat Commun"},{"key":"903_CR55","doi-asserted-by":"crossref","unstructured":"Salomon DR, Crisa L, Mojcik CF, et al. Vascular cell adhesion molecule-1 is expressed by cortical thymic epithelial cells and mediates thymocyte adhesion. Implications for the function of alpha4beta1 (VLA4) integrin in T-cell development [J]. Blood.1997, 1;89(7):2461-71.","DOI":"10.1182\/blood.V89.7.2461"},{"issue":"1","key":"903_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1073\/pnas.1314209111","volume":"111","author":"YI Choi","year":"2014","unstructured":"Choi YI, Duke-Cohan JS, Chen W, et al. Dynamic control of beta1 integrin adhesion by the plexind1-sema3e axis [J]. Proc Natl Acad Sci U S A. 2014;111(1):379\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"903_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1084\/jem.20021765","volume":"197","author":"Q Yu","year":"2003","unstructured":"Yu Q, Erman B, Bhandoola A, et al. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells [J]. J Exp Med. 2003;197(4):475\u201387.","journal-title":"J Exp Med"},{"key":"903_CR58","doi-asserted-by":"crossref","unstructured":"Lins MP, Silva ECO, Silva GR et al. Association between biomechanical alterations and migratory ability of semaphorin-3a-treated thymocytes [J]. Biochimica et biophysica acta (BBA) - General subjects. 2018;1862(4): 816\u201324.","DOI":"10.1016\/j.bbagen.2018.01.001"},{"issue":"3","key":"903_CR59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10517-020-04707-x","volume":"168","author":"KV Rutto","year":"2020","unstructured":"Rutto KV, Lyudyno VI, Kudryavtsev IV, et al. Semaphorin-3a inhibits proliferation, but does not affect apoptosis of mouse thymocytes in vitro [J]. Bull Exp Biol Med. 2020;168(3):352\u20135.","journal-title":"Bull Exp Biol Med"},{"issue":"10","key":"903_CR60","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1182\/blood-2009-08-237784","volume":"115","author":"DA Zlotoff","year":"2010","unstructured":"Zlotoff DA, Sambandam A, Logan TD, et al. CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus [J]. Blood. 2010;115(10):1897\u2013905.","journal-title":"Blood"},{"issue":"6","key":"903_CR61","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.immuni.2008.10.008","volume":"29","author":"YI Choi","year":"2008","unstructured":"Choi YI, Duke-Cohan JS, Ahmed WB, et al. PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla [J]. Immunity. 2008;29(6):888\u201398.","journal-title":"Immunity"},{"issue":"7","key":"903_CR62","doi-asserted-by":"publisher","first-page":"e103405","DOI":"10.1371\/journal.pone.0103405","volume":"9","author":"DA Mendes-Da-Cruz","year":"2014","unstructured":"Mendes-Da-Cruz DA, Brignier AC, Asnafi V, et al. Semaphorin 3f and neuropilin-2 control the migration of human T-cell precursors [J]. PLoS ONE. 2014;9(7):e103405.","journal-title":"PLoS ONE"},{"key":"903_CR63","doi-asserted-by":"crossref","unstructured":"Schwab SR, Pereira JP, Matloubian M, et al. Lymphocyte sequestration through S1P lyase Inhibition and disruption of S1P gradients [J]. Sci 2005, 9;309(5741):1735\u20139.","DOI":"10.1126\/science.1113640"},{"issue":"11","key":"903_CR64","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3298","volume":"12","author":"JP Girard","year":"2012","unstructured":"Girard JP, Moussion C, Forster R. Hevs, lymphatics and homeostatic immune cell trafficking in lymph nodes [J]. Nat Rev Immunol. 2012;12(11):762\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"903_CR65","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1182\/blood-2009-11-254334","volume":"116","author":"RT Boscacci","year":"2010","unstructured":"Boscacci RT, Pfeiffer F, Gollmer K, et al. Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing [J]. Blood. 2010;116(6):915\u201325.","journal-title":"Blood"},{"issue":"1","key":"903_CR66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1158\/2326-6066.CIR-21-0061","volume":"10","author":"W Celus","year":"2022","unstructured":"Celus W, Oliveira AI, Rivis S, et al. Plexin-A4 mediates cytotoxic T-cell trafficking and exclusion in cancer [J]. Cancer Immunol Res. 2022;10(1):126\u201341.","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"903_CR67","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.immuni.2013.08.034","volume":"39","author":"SE Henrickson","year":"2013","unstructured":"Henrickson SE, Perro M, Loughhead SM, et al. Antigen availability determines CD8+ T cell-dendritic cell interaction kinetics and memory fate decisions [J]. Immunity. 2013;39(3):496\u2013507.","journal-title":"Immunity"},{"issue":"8","key":"903_CR68","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2005-06-2445","volume":"107","author":"A Catalano","year":"2006","unstructured":"Catalano A, Caprari P, Moretti S, et al. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function [J]. Blood. 2006;107(8):3321\u20139.","journal-title":"Blood"},{"key":"903_CR69","doi-asserted-by":"crossref","unstructured":"Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH. Antigen-driven effector CD8\u207a T cell function regulated by T-bet. Proc Natl Acad Sci U S A. 2003;100(26):15818\u201315823.","DOI":"10.1073\/pnas.2636938100"},{"key":"903_CR70","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3389\/fimmu.2018.02981","volume":"9","author":"J Li","year":"2018","unstructured":"Li J, He Y, Hao J, et al. High levels of Eomes promote exhaustion of anti-tumor CD8+ T cells [J]. Front Immunol. 2018;9:2981.","journal-title":"Front Immunol"},{"issue":"6","key":"903_CR71","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/ni.3438","volume":"17","author":"KN Pollizzi","year":"2016","unstructured":"Pollizzi KN, Sun IH, Patel CH, et al. Asymmetric inheritance of mtorc1 kinase activity during division dictates CD8 (+) T cell differentiation [J]. Nat Immunol. 2016;17(6):704\u201311.","journal-title":"Nat Immunol"},{"issue":"3","key":"903_CR72","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.4049\/jimmunol.169.3.1175","volume":"169","author":"A Kumanogoh","year":"2002","unstructured":"Kumanogoh A, Suzuki K, Ch\u2019ng E, et al. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells [J]. J Immunol. 2002;169(3):1175\u201381.","journal-title":"J Immunol"},{"key":"903_CR73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2020.08.009","volume":"129","author":"E Kuklina","year":"2021","unstructured":"Kuklina E, Nekrasova I, Glebezdina N. Signaling from membrane semaphorin 4d in T lymphocytes [J]. Mol Immunol. 2021;129:56\u201362.","journal-title":"Mol Immunol"},{"key":"903_CR74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fimmu.2017.00765","volume":"8","author":"X Jiang","year":"2017","unstructured":"Jiang X, Bjorkstrom NK, Melum E. Intact CD100-CD72 interaction necessary for TCR-induced T cell proliferation [J]. Front Immunol. 2017;8:765.","journal-title":"Front Immunol"},{"issue":"3","key":"903_CR75","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/blood-2010-12-324848","volume":"119","author":"EM Eriksson","year":"2012","unstructured":"Eriksson EM, Milush JM, Ho EL, et al. Expansion of CD8+ T cells lacking sema4D\/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity [J]. Blood. 2012;119(3):745\u201355.","journal-title":"Blood"},{"issue":"1","key":"903_CR76","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4049\/jimmunol.1403096","volume":"196","author":"A Van Rijn","year":"2016","unstructured":"Van Rijn A, Paulis L, Te Riet J, et al. Semaphorin 7a promotes chemokine-driven dendritic cell migration [J]. J Immunol. 2016;196(1):459\u201368.","journal-title":"J Immunol"},{"issue":"7","key":"903_CR77","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/ni.1885","volume":"11","author":"H Takamatsu","year":"2010","unstructured":"Takamatsu H, Takegahara N, Nakagawa Y, et al. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II [J]. Nat Immunol. 2010;11(7):594\u2013600.","journal-title":"Nat Immunol"},{"issue":"10","key":"903_CR78","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41379-019-0291-z","volume":"32","author":"Y Masugi","year":"2019","unstructured":"Masugi Y, Abe T, Ueno A, et al. Characterization of Spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival [J]. Mod Pathol. 2019;32(10):1495\u2013507.","journal-title":"Mod Pathol"},{"issue":"1","key":"903_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41698-025-00831-x","volume":"9","author":"L Yang","year":"2025","unstructured":"Yang L, Yang H, Zhao M, et al. Stage-dependent Spatial distribution and prognostic value of CD8+ T tissue-resident memory T cells in NSCLC [J]. NPJ Precis Oncol. 2025;9(1):51.","journal-title":"NPJ Precis Oncol"},{"key":"903_CR80","doi-asserted-by":"publisher","first-page":"1138054","DOI":"10.3389\/fimmu.2023.1138054","volume":"14","author":"C Yan","year":"2023","unstructured":"Yan C, Huang H, Zheng Z, et al. Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer [J]. Front Immunol. 2023;14:1138054.","journal-title":"Front Immunol"},{"issue":"32","key":"903_CR81","doi-asserted-by":"publisher","first-page":"E6585","DOI":"10.1073\/pnas.1710751114","volume":"114","author":"AT Ritter","year":"2017","unstructured":"Ritter AT, Kapnick SM, Murugesan S, et al. Cortical actin recovery at the immunological synapse leads to termination of lytic granule secretion in cytotoxic T lymphocytes [J]. Proc Natl Acad Sci U S A. 2017;114(32):E6585\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"903_CR82","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1073\/pnas.1218640110","volume":"110","author":"F Bertrand","year":"2013","unstructured":"Bertrand F, Muller S, Roh KH, et al. An initial and rapid step of lytic granule secretion precedes microtubule organizing center polarization at the cytotoxic T lymphocyte\/target cell synapse [J]. Proc Natl Acad Sci U S A. 2013;110(15):6073\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"903_CR83","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.devcel.2022.08.012","volume":"57","author":"MA Govendir","year":"2022","unstructured":"Govendir MA, Kempe D, Sianati S, et al. T cell cytoskeletal forces shape synapse topography for targeted Lysis via membrane curvature bias of Perforin [J]. Dev Cell. 2022;57(18):2237\u2013e478.","journal-title":"Dev Cell"},{"issue":"2","key":"903_CR84","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00262-024-03893-1","volume":"74","author":"B Zhang","year":"2025","unstructured":"Zhang B, Liu Q, Li L, et al. Therapeutic effect of fully human anti-nrp-1 antibody on non-small cell lung cancer in vivo and in vitro [J]. Cancer Immunol Immunother. 2025;74(2):50.","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"903_CR85","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41590-020-0733-2","volume":"21","author":"C Liu","year":"2020","unstructured":"Liu C, Somasundaram A, Manne S, et al. Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity [J]. Nat Immunol. 2020;21(9):1010\u201321.","journal-title":"Nat Immunol"},{"issue":"5","key":"903_CR86","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/0008-5472.CAN-24-2223","volume":"3","author":"H Chi","year":"2025","unstructured":"Chi H, Deng S, Xu K, et al. Sema3G-NRP1 signaling functions as an immune checkpoint that enables tumor immune evasion by impairing T-cell cytotoxicity [J]. Cancer Res. 2025;3(5):912\u201324.","journal-title":"Cancer Res"},{"key":"903_CR87","doi-asserted-by":"crossref","unstructured":"Naito Y, Koyama S, Masuhiro K, et al. Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation [J]. Sci Adv. 2023, 19;9(20):eade0718.","DOI":"10.1126\/sciadv.ade0718"},{"issue":"5","key":"903_CR88","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.4049\/jimmunol.2100076","volume":"207","author":"Y Suga","year":"2021","unstructured":"Suga Y, Nagatomo I, Kinehara Y, et al. Il-33 induces sema4a expression in dendritic cells and exerts antitumor immunity [J]. J Immunol. 2021;207(5):1456\u201367.","journal-title":"J Immunol"},{"key":"903_CR89","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12885-016-2577-6","volume":"16","author":"T Ikeya","year":"2016","unstructured":"Ikeya T, Maeda K, Nagahara H, et al. The combined expression of semaphorin4d and plexinb1 predicts disease recurrence in colorectal cancer [J]. BMC Cancer. 2016;16:525.","journal-title":"BMC Cancer"},{"issue":"20","key":"903_CR90","doi-asserted-by":"publisher","first-page":"e70142","DOI":"10.1111\/jcmm.70142","volume":"28","author":"Z Xuan","year":"2024","unstructured":"Xuan Z, Zhang Y, Li D, et al. Plxnb1\/sema4d signals mediate interactions between malignant epithelial and immune cells to promote colorectal cancer liver metastasis [J]. J Cell Mol Med. 2024;28(20):e70142.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"903_CR91","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/ijc.31958","volume":"144","author":"Y Xia","year":"2019","unstructured":"Xia Y, Cai XY, Fan JQ, et al. The role of sema4d in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms [J]. Int J Cancer. 2019;144(9):2227\u201338.","journal-title":"Int J Cancer"},{"issue":"9","key":"903_CR92","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/2326-6066.CIR-23-0289","volume":"12","author":"G Franzolin","year":"2024","unstructured":"Franzolin G, Brundu S, Cojocaru CF, et al. Plexinb1 inactivation reprograms immune cells in the tumor microenvironment, inhibiting breast cancer growth and metastatic dissemination [J]. Cancer Immunol Res. 2024;12(9):1286\u2013301.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"903_CR93","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/imm.13189","volume":"160","author":"HM Wang","year":"2020","unstructured":"Wang HM, Zhang XH, Ye LQ, et al. Insufficient CD100 shedding contributes to suppression of CD8+ T cell activity in non-small cell lung cancer [J]. Immunology. 2020;160(2):209\u201319.","journal-title":"Immunology"},{"issue":"1","key":"903_CR94","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5603\/EP.a2020.0072","volume":"72","author":"XJ Lv","year":"2021","unstructured":"Lv XJ, Chen X, Wang Y, et al. Aberrant expression of semaphorin 6B affects cell phenotypes in thyroid carcinoma by activating the Notch signalling pathway [J]. Endokrynol Pol. 2021;72(1):29\u201336.","journal-title":"Endokrynol Pol"},{"key":"903_CR95","doi-asserted-by":"crossref","unstructured":"Hirai T, Naito Y, Koyama S, et al. Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer [J]. JCI Insight. 2024;9(3).","DOI":"10.1172\/jci.insight.166349"},{"issue":"1","key":"903_CR96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41368-024-00289-w","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Meng X, Zhang Y, et al. FUT8-mediated aberrant N-glycosylation of sema7A promotes head and neck squamous cell carcinoma progression [J]. Int J Oral Sci. 2024;16(1):26.","journal-title":"Int J Oral Sci"},{"issue":"5","key":"903_CR97","doi-asserted-by":"publisher","first-page":"115676","DOI":"10.1016\/j.celrep.2025.115676","volume":"44","author":"AM Elder","year":"2025","unstructured":"Elder AM, Fairchild HR, Kines KT, et al. Semaphorin7A and PD-L1 cooperatively drive immunosuppression during mammary Involution and breast cancer [J]. Cell Rep. 2025;44(5):115676.","journal-title":"Cell Rep"},{"issue":"13","key":"903_CR98","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1158\/0008-5472.CAN-16-3199","volume":"77","author":"D Wang","year":"2017","unstructured":"Wang D, Sun H, Wei J, et al. CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer [J]. Cancer Res. 2017;77(13):3655\u201365.","journal-title":"Cancer Res"},{"issue":"12","key":"903_CR99","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1111\/cas.13809","volume":"109","author":"H Shi","year":"2018","unstructured":"Shi H, Han X, Sun Y, et al. Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells [J]. Cancer Sci. 2018;109(12):3826\u201339.","journal-title":"Cancer Sci"},{"issue":"1","key":"903_CR100","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1038\/s41598-022-10029-x","volume":"12","author":"N Lin","year":"2022","unstructured":"Lin N, Chen L, Zhang Y, et al. Kif4a promotes tumor progression of bladder cancer via CXCL5 dependent myeloid-derived suppressor cells recruitment [J]. Sci Rep. 2022;12(1):6015.","journal-title":"Sci Rep"},{"issue":"6","key":"903_CR101","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccr.2013.11.007","volume":"24","author":"A Casazza","year":"2013","unstructured":"Casazza A, Laoui D, Wenes M, et al. Impeding macrophage entry into hypoxic tumor areas by sema3A\/NRP1 signaling blockade inhibits angiogenesis and restores antitumor immunity [J]. Cancer Cell. 2013;24(6):695\u2013709.","journal-title":"Cancer Cell"},{"issue":"10","key":"903_CR102","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/1541-7786.MCR-18-0933","volume":"17","author":"J Yang","year":"2019","unstructured":"Yang J, Zeng Z, Qiao L, et al. Semaphorin 4\u00a0C promotes macrophage recruitment and angiogenesis in breast cancer [J]. Mol Cancer Res. 2019;17(10):2015\u201328.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"903_CR103","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2567.2007.02737.x","volume":"123","author":"A Battaglia","year":"2008","unstructured":"Battaglia A, Buzzonetti A, Monego G, et al. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer [J]. Immunology. 2008;123(1):129\u201338.","journal-title":"Immunology"},{"issue":"7466","key":"903_CR104","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature12428","volume":"501","author":"GM Delgoffe","year":"2013","unstructured":"Delgoffe GM, Woo SR, Turnis ME, et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis [J]. Nature. 2013;501(7466):252\u20136.","journal-title":"Nature"},{"issue":"1","key":"903_CR105","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/2326-6066.CIR-19-0143","volume":"8","author":"K Jung","year":"2020","unstructured":"Jung K, Kim JA, Kim YJ, et al. A neuropilin-1 antagonist exerts antitumor immunity by inhibiting the suppressive function of intratumoral regulatory T cells [J]. Cancer Immunol Res. 2020;8(1):46\u201356.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"903_CR106","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A. CD8+ T cell differentiation and dysfunction in cancer [J]. Nat Rev Immunol. 2022;22(4):209\u201323.","journal-title":"Nat Rev Immunol"},{"issue":"7982","key":"903_CR107","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"AM Globig","year":"2023","unstructured":"Globig AM, Zhao S, Roginsky J, et al. The beta(1)-adrenergic receptor links sympathetic nerves to T cell exhaustion [J]. Nature. 2023;622(7982):383\u201392.","journal-title":"Nature"},{"issue":"4","key":"903_CR108","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy [J]. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"903_CR109","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, et al. Pembrolizumab versus ipilimumab in advanced melanoma [J]. N Engl J Med. 2015;372(26):2521\u201332.","journal-title":"N Engl J Med"},{"issue":"1","key":"903_CR110","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12943-025-02354-2","volume":"24","author":"J Yang","year":"2025","unstructured":"Yang J, Lu X, Cai Q, et al. Loss of tacc2 impairs chemokine CCL3 and CCL4 expression and reduces response to anti-PD-1 therapy in soft tissue sarcoma [J]. Mol Cancer. 2025;24(1):158.","journal-title":"Mol Cancer"},{"key":"903_CR111","doi-asserted-by":"crossref","unstructured":"Gide TN, Quek C, Menzies AM, et al. Distinct immune cell populations define response to anti-pd-1 monotherapy and anti-pd-1\/anti-ctla-4 combined therapy [J]. Cancer Cell. 2019;35(2):238\u2009\u2013\u200955 e6.","DOI":"10.1016\/j.ccell.2019.01.003"},{"key":"903_CR112","doi-asserted-by":"crossref","unstructured":"Wang D-R, Wu X-L, Sun Y-L. Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response [J]. Signal Transduct Target Therapy. 2022;7(1).","DOI":"10.1038\/s41392-022-01136-2"},{"issue":"4","key":"903_CR113","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/cas.14340","volume":"111","author":"S Nishio","year":"2020","unstructured":"Nishio S, Matsumoto K, Takehara K, et al. Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: subgroup analysis from the keynote-100 [J]. Cancer Sci. 2020;111(4):1324\u201332.","journal-title":"Cancer Sci"},{"issue":"19","key":"903_CR114","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G Jr., Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck [J]. N Engl J Med. 2016;375(19):1856\u201367.","journal-title":"N Engl J Med"},{"key":"903_CR115","doi-asserted-by":"crossref","unstructured":"De Vlaeminck Y, Bonelli S, Awad RM et al. Targeting neuropilin-1 with nanobodies reduces colorectal carcinoma development [J]. Cancers (Basel). 2020;12(12).","DOI":"10.3390\/cancers12123582"},{"key":"903_CR116","doi-asserted-by":"crossref","unstructured":"Fisher TL, Evans EE, Mallow CL, et al. Phase 1\/2 study of pepinemab, an inhibitor of semaphorin 4D, in combination with pembrolizumab as first-line treatment of recurrent or metastatic head and neck cancer (KEYNOTE-B84) [J]. J Clin Oncol. 2022;40(2022):e18033-e18033.","DOI":"10.1200\/JCO.2022.40.16_suppl.e18033"},{"issue":"3","key":"903_CR117","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12032-023-01970-6","volume":"40","author":"P Paranthaman","year":"2023","unstructured":"Paranthaman P, Veerappapillai S. Design of a potential sema4a-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach [J]. Med Oncol. 2023;40(3):105.","journal-title":"Med Oncol"},{"issue":"20","key":"903_CR118","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1158\/0008-5472.CAN-18-3436","volume":"79","author":"I Zuazo-Gaztelu","year":"2019","unstructured":"Zuazo-Gaztelu I, Paez-Ribes M, Carrasco P, et al. Antitumor effects of anti-semaphorin 4d antibody unravel a novel proinvasive mechanism of vascular-targeting agents [J]. Cancer Res. 2019;79(20):5328\u201341.","journal-title":"Cancer Res"},{"issue":"4","key":"903_CR119","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1158\/1535-7163.MCT-14-0924","volume":"14","author":"JE Leonard","year":"2015","unstructured":"Leonard JE, Fisher TL, Winter LA, et al. Nonclinical safety evaluation of VX15\/2503, a humanized IgG4 anti-sema4d antibody [J]. Mol Cancer Ther. 2015;14(4):964\u201372.","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"903_CR120","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-20-4792","volume":"27","author":"MR Shafique","year":"2021","unstructured":"Shafique MR, Fisher TL, Evans EE, et al. A phase Ib\/II study of Pepinemab in combination with avelumab in advanced non-small cell lung cancer [J]. Clin Cancer Res. 2021;27(13):3630\u201340.","journal-title":"Clin Cancer Res"},{"key":"903_CR121","doi-asserted-by":"crossref","unstructured":"Steuer CE, Evans EE, Fisher TL, et al. Neoadjuvant biomarker trial of pepinemab to enhance nivolumab or ipilimumab activity in resectable head and neck cancer [J]. J Clin Oncol. 2025;43(2025):103\u2013103.","DOI":"10.1200\/JCO.2025.43.16_suppl.103"},{"issue":"5","key":"903_CR122","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00280-014-2426-8","volume":"73","author":"A Patnaik","year":"2014","unstructured":"Patnaik A, Lorusso PM, Messersmith WA, et al. A phase Ib study evaluating mnrp1685a, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and Paclitaxel in patients with advanced solid tumors [J]. Cancer Chemother Pharmacol. 2014;73(5):951\u201360.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"903_CR123","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10637-014-0071-z","volume":"32","author":"CD Weekes","year":"2014","unstructured":"Weekes CD, Beeram M, Tolcher AW, et al. A phase I study of the human monoclonal anti-NRP1 antibody mnrp1685a in patients with advanced solid tumors [J]. Invest New Drugs. 2014;32(4):653\u201360.","journal-title":"Invest New Drugs"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00903-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:03:29Z","timestamp":1771517009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00903-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00903-5","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is not applicable for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}